Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles

Yutaka Kawakami, Paul F. Robbins, Xiang Wang, Janis P. Tupesis, Maria R. Parkhurst, Xiaoqiang Kang, Kazuyasu Sakaguchi, Ettore Appella, Steven A. Rosenberg

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

To isolate melanoma Ags recognized by T cells, cDNA libraries made from melanoma cell lines were screened with four CTLs derived from tumor infiltrating lymphocytes (TIL) that were able to recognize melanoma cells in a HLA-A1, -A2, or -A3 restricted manner. Although cDNAs encoding the previously identified melanoma Ags, tyrosinase and gp100, were isolated, these TIL were found to recognize previously unidentified peptides. An HLA- A1-restricted CTL, TIL1388, was found to recognize a tyrosinase peptide (SSDYVIPIGTY), and an HLA-A3-restricted CTL, TIL1351, recognized a gp100 peptide (LIYRRRLMK). CTL clones isolated from the HLA-A2-restricted TIL1383 recognized a gp100 peptide (RLMKQDFSV). HLA-A2-restricted CTL, TIL1200, recognized a gp100 peptide (RLPRIFCSC). Replacement of either cysteine residue with α-amino butyric acid in the gp100 peptide, RLPRIFCSC, enhanced CTL recognition, suggesting that the peptide epitope naturally presented on the tumor cell surface may contain reduced cysteine residues. Oxidation of these cysteines might have occurred during the course of the synthesis or pulsing of the peptide in culture. These modifications may have important implications for the development of efficient peptide-based vaccines. These newly identified peptide epitopes can extend the ability to perform immunotherapy using synthetic peptides to a broader population of patients, especially those expressing HLA-A1 or HLA-A3 for whom only a few melanoma epitopes have previously been identified.

Original languageEnglish
Pages (from-to)6985-6992
Number of pages8
JournalJournal of Immunology
Volume161
Issue number12
Publication statusPublished - 1998 Dec 15

Fingerprint

HLA-A1 Antigen
Tumor-Infiltrating Lymphocytes
HLA-A2 Antigen
Epitopes
Melanoma
Alleles
T-Lymphocytes
Peptides
Proteins
HLA-A3 Antigen
Cysteine
Monophenol Monooxygenase
Subunit Vaccines
Butyric Acid
Gene Library
Immunotherapy
Complementary DNA
Clone Cells

ASJC Scopus subject areas

  • Immunology

Cite this

Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., ... Rosenberg, S. A. (1998). Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. Journal of Immunology, 161(12), 6985-6992.

Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. / Kawakami, Yutaka; Robbins, Paul F.; Wang, Xiang; Tupesis, Janis P.; Parkhurst, Maria R.; Kang, Xiaoqiang; Sakaguchi, Kazuyasu; Appella, Ettore; Rosenberg, Steven A.

In: Journal of Immunology, Vol. 161, No. 12, 15.12.1998, p. 6985-6992.

Research output: Contribution to journalArticle

Kawakami, Y, Robbins, PF, Wang, X, Tupesis, JP, Parkhurst, MR, Kang, X, Sakaguchi, K, Appella, E & Rosenberg, SA 1998, 'Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles', Journal of Immunology, vol. 161, no. 12, pp. 6985-6992.
Kawakami, Yutaka ; Robbins, Paul F. ; Wang, Xiang ; Tupesis, Janis P. ; Parkhurst, Maria R. ; Kang, Xiaoqiang ; Sakaguchi, Kazuyasu ; Appella, Ettore ; Rosenberg, Steven A. / Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. In: Journal of Immunology. 1998 ; Vol. 161, No. 12. pp. 6985-6992.
@article{943510af7d4f405c9941296d2d903eaf,
title = "Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles",
abstract = "To isolate melanoma Ags recognized by T cells, cDNA libraries made from melanoma cell lines were screened with four CTLs derived from tumor infiltrating lymphocytes (TIL) that were able to recognize melanoma cells in a HLA-A1, -A2, or -A3 restricted manner. Although cDNAs encoding the previously identified melanoma Ags, tyrosinase and gp100, were isolated, these TIL were found to recognize previously unidentified peptides. An HLA- A1-restricted CTL, TIL1388, was found to recognize a tyrosinase peptide (SSDYVIPIGTY), and an HLA-A3-restricted CTL, TIL1351, recognized a gp100 peptide (LIYRRRLMK). CTL clones isolated from the HLA-A2-restricted TIL1383 recognized a gp100 peptide (RLMKQDFSV). HLA-A2-restricted CTL, TIL1200, recognized a gp100 peptide (RLPRIFCSC). Replacement of either cysteine residue with α-amino butyric acid in the gp100 peptide, RLPRIFCSC, enhanced CTL recognition, suggesting that the peptide epitope naturally presented on the tumor cell surface may contain reduced cysteine residues. Oxidation of these cysteines might have occurred during the course of the synthesis or pulsing of the peptide in culture. These modifications may have important implications for the development of efficient peptide-based vaccines. These newly identified peptide epitopes can extend the ability to perform immunotherapy using synthetic peptides to a broader population of patients, especially those expressing HLA-A1 or HLA-A3 for whom only a few melanoma epitopes have previously been identified.",
author = "Yutaka Kawakami and Robbins, {Paul F.} and Xiang Wang and Tupesis, {Janis P.} and Parkhurst, {Maria R.} and Xiaoqiang Kang and Kazuyasu Sakaguchi and Ettore Appella and Rosenberg, {Steven A.}",
year = "1998",
month = "12",
day = "15",
language = "English",
volume = "161",
pages = "6985--6992",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles

AU - Kawakami, Yutaka

AU - Robbins, Paul F.

AU - Wang, Xiang

AU - Tupesis, Janis P.

AU - Parkhurst, Maria R.

AU - Kang, Xiaoqiang

AU - Sakaguchi, Kazuyasu

AU - Appella, Ettore

AU - Rosenberg, Steven A.

PY - 1998/12/15

Y1 - 1998/12/15

N2 - To isolate melanoma Ags recognized by T cells, cDNA libraries made from melanoma cell lines were screened with four CTLs derived from tumor infiltrating lymphocytes (TIL) that were able to recognize melanoma cells in a HLA-A1, -A2, or -A3 restricted manner. Although cDNAs encoding the previously identified melanoma Ags, tyrosinase and gp100, were isolated, these TIL were found to recognize previously unidentified peptides. An HLA- A1-restricted CTL, TIL1388, was found to recognize a tyrosinase peptide (SSDYVIPIGTY), and an HLA-A3-restricted CTL, TIL1351, recognized a gp100 peptide (LIYRRRLMK). CTL clones isolated from the HLA-A2-restricted TIL1383 recognized a gp100 peptide (RLMKQDFSV). HLA-A2-restricted CTL, TIL1200, recognized a gp100 peptide (RLPRIFCSC). Replacement of either cysteine residue with α-amino butyric acid in the gp100 peptide, RLPRIFCSC, enhanced CTL recognition, suggesting that the peptide epitope naturally presented on the tumor cell surface may contain reduced cysteine residues. Oxidation of these cysteines might have occurred during the course of the synthesis or pulsing of the peptide in culture. These modifications may have important implications for the development of efficient peptide-based vaccines. These newly identified peptide epitopes can extend the ability to perform immunotherapy using synthetic peptides to a broader population of patients, especially those expressing HLA-A1 or HLA-A3 for whom only a few melanoma epitopes have previously been identified.

AB - To isolate melanoma Ags recognized by T cells, cDNA libraries made from melanoma cell lines were screened with four CTLs derived from tumor infiltrating lymphocytes (TIL) that were able to recognize melanoma cells in a HLA-A1, -A2, or -A3 restricted manner. Although cDNAs encoding the previously identified melanoma Ags, tyrosinase and gp100, were isolated, these TIL were found to recognize previously unidentified peptides. An HLA- A1-restricted CTL, TIL1388, was found to recognize a tyrosinase peptide (SSDYVIPIGTY), and an HLA-A3-restricted CTL, TIL1351, recognized a gp100 peptide (LIYRRRLMK). CTL clones isolated from the HLA-A2-restricted TIL1383 recognized a gp100 peptide (RLMKQDFSV). HLA-A2-restricted CTL, TIL1200, recognized a gp100 peptide (RLPRIFCSC). Replacement of either cysteine residue with α-amino butyric acid in the gp100 peptide, RLPRIFCSC, enhanced CTL recognition, suggesting that the peptide epitope naturally presented on the tumor cell surface may contain reduced cysteine residues. Oxidation of these cysteines might have occurred during the course of the synthesis or pulsing of the peptide in culture. These modifications may have important implications for the development of efficient peptide-based vaccines. These newly identified peptide epitopes can extend the ability to perform immunotherapy using synthetic peptides to a broader population of patients, especially those expressing HLA-A1 or HLA-A3 for whom only a few melanoma epitopes have previously been identified.

UR - http://www.scopus.com/inward/record.url?scp=0032534587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032534587&partnerID=8YFLogxK

M3 - Article

C2 - 9862734

AN - SCOPUS:0032534587

VL - 161

SP - 6985

EP - 6992

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -